James Vaughn
2018
In 2018, James Vaughn earned a total compensation of $1.6M as Chief U.S. Commercial Officer at Genomic Health, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $258,780 |
|---|---|
| Option Awards | $662,011 |
| Salary | $416,200 |
| Stock Awards | $225,496 |
| Total | $1,562,487 |
Vaughn received $662K in option awards, accounting for 42% of the total pay in 2018.
Vaughn also received $258.8K in non-equity incentive plan, $416.2K in salary and $225.5K in stock awards.
Rankings
In 2018, James Vaughn's compensation ranked 6,960th out of 14,244 executives tracked by ExecPay. In other words, Vaughn earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,960 out of 14,244 | 51st |
Division Services | 1,319 out of 2,374 | 44th |
Major group Health Services | 103 out of 218 | 53rd |
Industry group Medical And Dental Laboratories | 22 out of 76 | 71st |
Industry Medical Laboratories | 22 out of 76 | 71st |
Source: SEC filing on April 25, 2019.
Vaughn's colleagues
We found four more compensation records of executives who worked with James Vaughn at Genomic Health in 2018.